What Will Type 2 Diabetes Treatments Look Like in 5 Years? Merck & Co., Inc. (MRK), AstraZeneca plc (AZN)
Times are changing in the biotech sector.
Posts Tagged ‘Johnson & Johnson (JNJ)’
PIMCO’s Gross Makes Prescient Warning: Microsoft Corporation (MSFT), Genuine Parts Company (GPC)
"Bond investors take note: with current QE at 100 billion per month, any bonds worth < par are future road kill." Bill Gross, PIMCO.
3 Signs That Citigroup Inc. (C) Isn’t the Right Stock for You
Actually, the stock is really darn cheap. Currently trading at 0.7 times its book value, Citi's valuation is a fraction of what it was prior to the financial crisis.
A Board Member Bought Over $300,000 of Abbott Labs
A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and $33.90.
Building A Better Drug Portfolio: Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), Amgen, Inc. (AMGN)
When building a drug portfolio, most investors stick to pharmaceutical firms. Since these are generally the largest, most profitable options, it's easy to see why.
Is 3M Co (MMM) Rally Worth Chasing?
As we all know by now, stocks have had a great rally in the last few months, leaving the main benchmark indices trading at fairly high multiples.
Politicians Kick The Can, Investors Should Focus On Safety: McDonald’s Corporation (MCD), Wal-Mart Stores, Inc. (WMT)
When the House of Representatives agreed to a three month debt limit extension the market rallied.
As The Market Nears Its All-Time High, Should Investors Get Defensive? Exxon Mobil Corporation (XOM), Kimberly Clark Corp (KMB)
In October 2007, the Dow Jones Industrial Average hit its all-time high of just over 14,000. Unfortunately, most people know all too well what followed: the Great Recession...
$2 Billion Hedge Fund Seminole Capital’s Top Stock Picks for 2013
Hedge funds and other major investors file 13Fs within several weeks after the end of each quarter, disclosing many of their long equity positions.
Sex Sells: A Guide For the Socially Responsible Investor, Johnson & Johnson (JNJ), Pfizer Inc. (PFE)
Sex sells. You read this far, didn't you? Socially responsible investors are missing out on some very good companies if they maintain a prudish bent.
Two Peas in a Pharma Pod: Pfizer Inc (PFE), Bristol Myers Squibb Co. (BMY)
Pfizer's 2012 revenue was down 10%; Bristol-Myers Squibb's was off by 17%. Both are down because of expirations of megablockbusters they used to own.
Intuitive Surgical, Inc. (ISRG): Trade-In Sales Data Help Confirm Bullish Case
Intuitive Surgical, Inc.
3M Co (MMM): What Kind of Return Can Investors Expect from This Stock?
One of the best things about investing in blue chip stocks is their predictable business results.
Mixed Housing Data Has No Effect on the Dow: The Boeing Company (BA), Johnson & Johnson (JNJ), Caterpillar Inc. (CAT)
The National Association of Realtors released data this morning indicating that December's existing-home sales fell by 1% from November.
Will Johnson & Johnson (JNJ) Earnings Move the Dow?
With dozens of companies having already reported quarterly results, we're now in the heart of earnings season.
Billionaire Ken Fisher’s Latest Stock Picks Include Pfizer and Visa
Fisher Asset Management, which is managed by billionaire investor/author/Forbes columnist Ken Fisher, has released its 13F filing for December 2012, disclosing many of its long...
Is Johnson & Johnson a Good Stock to Buy?
Johnson & Johnson (NYSE:JNJ) currently trades at 23 times trailing earnings, which we’d normally consider to be a bit high for a stable consumer health and healthcare company...
A Growth ETF For 2013
With just a few trading days left in 2012, it is fair to say, broadly speaking, that the soon-to-be completed year was kind to growth stocks.
Why Merck & Co., Inc. (MRK) Is Still A Top Notch Drug Company
Merck & Co., Inc. (NYSE:MRK) was down over 5% following disapproval of its latest cholesterol-related drug.
Ken Fisher & Jim Simons: Two Billionaires Bulking Up On Drugs
Billionaires Ken Fisher and Jim Simons are two of the top names in the money management business.
Best 5 Dividend Stocks of the Dow 30
Blue chip companies in the DJIA, with proven earnings power and consistent dividend growth, are some of the best dividend plays out there.
Earnings Analysis: Medtronic Inc. (NYSE:MDT)
Medtronic, Inc. (NYSE:MDT) recently reported its preliminary financial results based on which we provide a unique peer-based analysis of the company.
JNJ, RIMM, WFC, USB: Prem Watsa’s Top Stock Picks From Q3
Fairfax Financial recently filed its 3Q 13F with the SEC, which reveals the holdings of hedge funds and other notable investors.
Pfizer, Johnson & Johnson, Merck: 10 Pharma Stocks Hedge Funds Love
After identifying the ten most popular stocks among hedge funds according to their third quarter 13F filings, we have decided to break down the top ten stocks that hedge funds...
Warren Buffett News: You’re not Warren Buffett, so don’t invest like him
Warren Buffett is the world’s greatest investor and an inspiration to all – but that doesn’t mean you should be copying his stock market moves.
Warren Buffett News: Would You Have Fired Warren Buffett?
When should you think about firing your investment manager? There are many differences of opinion.
Four High Yield Stocks From Warren Buffett’s Portfolio
Quarterly 13F filings disclose what hedge funds and other notable investors owned at the end of a quarter (which is about six or seven weeks ago by the time the 13Fs are generally...
$5 Billion Hedge Fund’s 5 Dividend Stocks
PointState Capital is a money management firm with some $5 billion in assets under management.
Billionaire George Soros’s Latest Stock Picks
George Soros is best known for the fortune he made shorting the British pound in 1992, but he currently invests a considerable amount of money in equities and so is required to...
Warren Buffett and Berkshire Now Hold Deere, Cut GE, JNJ and UPS
There are few people whose words can move entire markets, and Warren Buffett is once such man.
Billionaire Kerr Neilson’s Latest Stock Picks
Billionaire Kerr Neilson is the founder and manager of Platinum Asset Management, a large Australia-based investment firm which invests globally.
Apple Inc (AAPL), Google Inc (GOOG) Among the Stocks RenTech Downsized In Q3
Apple Inc (NASDAQ:AAPL) was just one of the top-name stocks that Renaissance Technologies was dumping during the third quarter.
George Soros’ 7 Favorite Dividend Stock Picks
George Soros is the founder and chairman of hedge fund Soros Fund Management LLC.
Earnings Analysis: 3M Co. (NYSE:MMM)
3M Co (NYSE:MMM) recently reported its preliminary financial results based on which we provide a unique peer-based analysis of the company.
Arena Pharma (ARNA), Vivus (VVUS): Which Hedge Funds Made the Wrong Pharma Bets?
Since the end of 2Q, the very popular biopharma companies, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and Vivus, Inc.
3 High-Yield Pharma Stocks With Major Catalysts
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck & Co., Inc.
Walgreen: How It Plans on Realizing $1 BIllion in Synergies
In my last article on Walgreen Company (NYSE:WAG), I gave light on pressing issues revolving around the world’s largest drugstore.
Is Johnson & Johnson a Good Stock to Buy?
Johnson & Johnson (NYSE:JNJ) took a hit to its earnings in the second quarter of the year, with net income falling by about half compared to its results in the second quarter ...
Is 3M a Good Stock to Buy?
3M Co (NYSE:MMM) isn’t flashy, but the $66 billion market cap conglomerate has been getting steady growth in earnings per share this year.
Billionaire Ken Fisher’s Favorite Mega-Cap Stocks
As John Templeton famously said, bull markets grown on skepticism die on euphoria. Ken Fisher, fund manager for Fisher Asset Management, is a firm believer in Templeton’s view...
Barton Biggs’s Top 5 Stock Picks
Barton Biggs and his firm Traxis Partners began a pivot of their portfolio in the second quarter and refrained from making any bold bets before Biggs passed away in July 2012 ...
Philip Hempleman’s Top Stock Picks
Philip Hempleman founded Ardsley Partners in 1987. Connecticut-based Ardsley is a long/short equity hedge fund with approximately $1 billion under management.
Dendreon: All Eyes Are On The Balance Sheet
Dendreon Corporation (NASDAQ:DNDN) is your typical biotech story where stagnant sales, a competitive landscape, and a high cash burn ultimately leave the company in the hands ...
Why is This Biotech Company Baker Bros.’ Top Stock Pick?
Baker Bros. Advisors, managed by – you guessed it – Julian and Felix Baker, had quite the second quarter this year.
These Stocks Are D.E. Shaw’s Top Dividend Plays
D.E. Shaw & Co., LP, founded by D.E. Shaw in 1988, is a New York-based investment management firm managing over $26 billion in investment capital.
Warren Buffett News: Inside Warren Buffett’s Private Poker Tournament
Via Forbes comes a read on what it’s like to go to Warren Buffett’s private poker tournament from staff writer Randall Lane, who scored an invite to Berkshire Hathaway’s...
Hedge Fund News: T Boone Pickens, Andrew Hall, Citi
T. Boone Pickens, who made his billions on oil, is adding to them on the back of the commodity this year.
Warren Buffett News: Does Warren Buffett Have An Ally?
My post of Monday August 20 closed with the following comment: “as one reads a book like ‘More Money Than God’ by Sebastian Mallaby, one observes that lots and lots of money...
